Afinitor (everolimus)

pCPA File Number: 20766

Negotiation Status:

Concluded with an LOI

Indication(s):

Pancreatic Neuroendocrine Tumors

Sponsor/Manufacturer:

Novartis Pharmaceuticals Canada Inc.

CDA-AMC Project Number:

PC0007-000

pCPA Engagement Letter Issued:

2013-08-26

Negotiation Process Concluded:

2013-10-11